LifeVantage to Present at the ICR Conference 2017

SALT LAKE CITY, Jan. 04, 2017 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), announced today that Darren Jensen, the Company's President and Chief Executive Officer will be presenting at the ICR Conference 2017, to be held January 9-11, 2017, at the JW Marriott Orlando Grande Lakes in Orlando, Florida.

LifeVantage Corporation’s investor presentation is scheduled for Wednesday, January 11, 2017, at 10:00 a.m. Eastern Time. The presentation will be webcast live and archived on the Investor Info portion of the Company's website at http://investor.lifevantage.com/events.cfm.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq:LFVN), is a science-based direct selling company dedicated to visionary science that looks to transform health, wellness and anti-aging internally and externally at the cellular level. The company is the maker of Protandim® Nrf2 and NRF1 Synergizers, its line of scientifically-validated dietary supplements, the TrueScience® Anti-Aging Skin Care Regimen, Canine Health®, the AXIO® energy product line and the PhysIQ™ Smart Weight Management System. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah.  www.lifevantage.com

Investor Relations Contacts:
                    
                    Cindy England 
                    Director of Investor Relations
                    (801) 432-9036
                    investor@lifevantage.com
                    
                    -or-
                    
                    Scott Van Winkle 
                    Managing Director, ICR 
                    (617) 956-6736
                    scott.vanwinkle@icrinc.com
                    
                    Company Relations Contact: 
                    
                    John Genna 
                    Vice President of Communications 
                    & Corporate Partnerships
                    (801) 432-9172